Park Dental Partners 2026 Q3 Earnings Call
Review the key takeaways and the transcript of this earnings call.
- Third-quarter 2026 revenue was $64.9 million, up 6% year over year, including same-practice revenue growth of 3.2%.
- Revenue growth was primarily driven by favorable reimbursement trends, acquisitions completed in the past 12 months, and growth in clinical hours; those acquisitions contributed approximately $1.2 million of revenue in the quarter.
- Patient visits were approximately 181,000 and patient retention was 90.2%.
- Third-quarter gross margin was $8.2 million, and adjusted gross margin was $12.1 million, or 18.6% of revenue; adjusted gross margin increased modestly in dollars but declined 80 basis points as a percentage of revenue.
- Third-quarter net income was $1.7 million, or $0.27 per diluted share, and adjusted EBITDA was $5 million, or 7.7% of revenue, compared with $5.3 million, or 8.7% of revenue, in the prior-year period.
- Adjusted diluted earnings per share was $0.57 compared with $1.19 in the prior-year period.
- Management attributed lower gross margin primarily to higher salaries and benefits expense, including doctor share-based compensation associated with the transition to a public company.
- The quarter’s adjusted EBITDA was affected by investment in hygienist hiring and an estimated $500,000 impact from a cybersecurity event, including temporary production disruption and professional fees.
- At September 30th, Park Dental Partners had $23.2 million of cash and cash equivalents, approximately $10.6 million of total debt, and an undrawn $15 million revolving credit facility.
- Operating cash flows were $12 million in the first 9 months of 2026, compared with $16.8 million in the prior-year period, primarily due to the timing of working capital; year-to-date capital investments were $7.6 million.
- Village Family Dental closed after quarter end and was not included in third-quarter financial performance; it brings 47 doctors across 12 practices and expands the company into its 4th state, North Carolina.
- Village generated approximately $45 million of revenue in 2024 and $50 million in 2025, with historical adjusted EBITDA margins of approximately 10%.
- The Village transaction included $39.1 million of base consideration and $6.9 million of contingent consideration; 475,000 shares represented approximately 24% of the consideration.
- In conjunction with the Village closing, Park Dental Partners amended its credit facility to expand the line of credit from $15 million to $25 million.
STOCKNOW INSIGHTS
Continue with outlook and guidance.
Log in to unlock executive comments and Q&A highlights.
Log in for the full summaryStockNow uses AI to translate and summarize earnings calls. Accuracy and completeness are not guaranteed.
Transcript
Preview the first fifteen paragraphs, organized by speaker.
Good morning, and welcome to Park Dental Partners Third Quarter 2026 Earnings Conference Call. Today's call is being recorded, and at this time, all participants are in listen-only mode. Following the prepared remarks, management will open the call for questions from its analysts. Certain statements made during the call today constitute forward-looking statements made pursuant to and within the meaning of the Safe Harbor Provisions of the Private Securities Litigation Reform Act of 1995 as amended. Such forward-looking statements are subject to both known and unknown risks and uncertainties that could cause actual results to differ materially from such statements. Those risks and uncertainties are described in the company's earnings press release issued yesterday and in the company's filings with the SEC. The forward-looking statements made today are as of the date of this call, and the company does not undertake any obligation to update the forward-looking statements.
Please note the terms company, we, our, and us refers to Park Dental Partners, Inc., and its affiliated dental practices. Today's call will also include certain non-GAAP measurements. Please see the company's earnings press release for a reconciliation of those non-GAAP financial measures. The press release is available on the company's website. I will now turn the call over to Pete Swenson, Chief Executive Officer and Chair of the Board for Park Dental Partners, Inc.
Good morning, everyone, and thank you for joining Park Dental Partners Third Quarter 2026 Earnings Call. Joining me today is our CFO, CJ Bernander. Before discussing our results, I want to begin by thanking our doctors and team members across the organization, including our newest doctors and team members in North Carolina. Every day, thousands of patients place their trust in us. We earn that trust one patient at a time through the clinical excellence, dedication, and professionalism of our people. That commitment is reflected in the three priorities that continue to guide our organization. That is our focus on our patients, our people, and our performance. These priorities are closely connected. Delivering high-quality care and a great patient experience requires talented and engaged people, and when we consistently deliver in these areas, strong and sustainable financial performance follows.
A significant milestone for our organization occurred this past week with the closing of our Village Family Dental transaction. Village brings 47 doctors across 12 practices into Park Dental Partners and expands our reach into our fourth state, North Carolina. While this transaction meaningfully increases our scale, what makes it particularly compelling is the alignment between our two organizations. Village has built an outstanding culture with a long-standing reputation for high-quality clinical care, strong doctor leadership, and a commitment to the communities it serves. These are values that closely mirror our own. We are honored that Village Family's doctor partners and leadership selected Park Dental Partners to help steward the next chapter of their organization. Our responsibility is to preserve the strengths that have made Village Family successful while providing the resources, infrastructure, and support to help its doctors and team members continue to thrive.
Our integration efforts are underway with an immediate emphasis on keeping patient schedules full to finish the year strong, support local leadership, and establishing the operational relationships and processes that will support long-term success. Over time, we see meaningful opportunities to share best practices, leverage our combined resources, and support continued growth across the organization. As we have said before, our growth strategy is more than just about adding practices. It is about bringing together people with shared values, strong clinical leadership, and the potential to create lasting value. Village Family Dental represents an important step forward in that strategy. CJ will provide additional details regarding the transaction and its impact on our updated full-year outlook. Turning to the third quarter, our results reflect continued progress in executing on our long-term growth strategy. We grew revenue, expanded our affiliated doctor base, and continued investing in clinical capacity to serve more patients.
Third quarter revenue increased 6% year-over-year, including same-practice revenue growth of 3.2%. Patient retention remained above 90%, and with Village Family, we now have 272 affiliated doctors. We also expanded our footprint in Arizona through the acquisition of Sapphire Dental in September. Importantly, our third quarter top-line results remain consistent with our expectations. We continue to believe the combination of consistent organic growth, disciplined investment, and increasing scale positions Park Dental Partners well for the years ahead. From an operational perspective, we continued to make progress expanding our clinical capacity during the quarter. Recruiting and retaining talented doctors and team members remains a central priority because our ability to grow organically depends on having the clinical resources available to meet patient demand. Of note, we have increased our team of hygienists by over 8% in the third quarter.
Our team saw a market opportunity and capitalized on a hiring initiative that will drive increased capacity for 2027. There will be some additional costs in the second half of this year to onboard and ramp up these new team members, but we view these investments in capacity as an important foundation for future growth. As newly added doctors and hygienists build their patient schedules and increase production, we expect to benefit from improved utilization of our existing facilities and infrastructure. Our focus is on converting that additional capacity into revenue growth and stronger operating margins. Looking ahead, our long-term growth strategy remains unchanged. We intend to grow organically by expanding clinical capacity and improving productivity within our existing practices while complementing that growth through affiliations with high-quality dental practices, selective de novo development, and thoughtful geographic expansion.
Our acquisition pipeline remains strong from single practice targets to large dental groups, and we will selectively add practices and doctors that align with our values. The addition of Village Family Dental is a meaningful example of that strategy in action. We will remain focused on disciplined execution and integration, thoughtful capital allocation, and building an organization that creates long-term value for all stakeholders, our patients, our people, and our shareholders. Our foundation continues to be a patient-first culture, a commitment to doctors and leadership in both governance and management of the organization, and a long-term commitment to clinical excellence. We believe those attributes distinguish Park Dental Partners and provide a strong foundation for continued growth. With that, I will turn the call over to CJ for a more detailed review of our financial results and outlook.
Thanks, Pete. Good morning, everyone. We were pleased with third-quarter revenue, as the quarter was in line with our expected growth, totaling $64.9 million, an increase of 6% over the prior year period. Revenue growth was primarily driven by favorable reimbursement trends, acquisitions completed in the past 12 months, and growth in clinical hours. Acquisitions completed during the trailing 12 months contributed approximately $1.2 million of revenue in the quarter. Same-practice revenue growth was 3.2% for the quarter, which was a slight acceleration from the second quarter. Patient visits were approximately 181,000 during the quarter, and patient retention was 90.2%. We ended the quarter with 225 affiliated doctors across 88 practice locations. With the Village transaction, we now have 272 doctors and 100 practices. Turning to profitability, gross margin was $8.2 million for the third quarter, with adjusted gross margin of $12.1 million, or 18.6% of revenue.
The decline in gross margin was primarily driven by higher salaries and benefits expense, including doctor share-based compensation associated with our transition to a public company. Adjusted gross margin increased modestly in dollars, but declined 80 basis points as a percentage of revenue. Third-quarter net income was $1.7 million, or $0.27 per diluted share, reflecting our share count increase from our December IPO. Adjusted EBITDA was $5 million, or 7.7% of revenue, compared with $5.3 million, or 8.7% of revenue. A couple of things impacted our Adjusted EBITDA in the third quarter. One, as Pete mentioned, we invested in our team of hygienists with a goal of seeing increased production in the future. We are pleased with what we are seeing so far and expect to drive increased production in 2027.
The other was a $500,000 impact related to the cybersecurity event that we had earlier in the quarter. Although all indications are that the disruption was minimal, we estimate the $500,000 impact by factoring in temporary production disruption for a few days and professional fees related to the event. While this event affected our third-quarter results, it has not changed the underlying fundamentals of the business. Adjusted diluted earnings per share was $0.57 compared to $1.19 in the prior year period. As has been the case all year, we are seeing the impact of EPS of becoming a public reporting company in December 2025. We look forward to more meaningful comparisons next year. Overall, we are pleased with our performance during the quarter. At September 30th, we had $23.2 million of cash and cash equivalents and approximately $10.6 million of total debt.
Our $15 million revolving credit facility was undrawn at quarter end. Operating cash flows were $12 million in the first nine months of 2026, compared with $16.8 million in the prior year period. The year-over-year change is primarily driven by the timing of working capital, and year-to-date capital investments were $7.6 million. After quarter end, we utilized a portion of cash on hand and part of our existing credit facility to close the Village Family transaction. For some additional context on Village, let me start by reiterating what Pete said earlier. We are pleased to bring on such a quality organization. Village generated approximately $45 million of revenue in 2024 and $50 million in 2025, with historical Adjusted EBITDA margins of approximately 10%. We think that provides a useful perspective on the historical scale and financial profile of the business.
We view Village as an attractive business on a standalone basis, and our acquisition thesis does not depend on achieving significant synergies. We do, however, see opportunities over time to leverage the combined organization's scale, capabilities, and resources to create additional value. We also expect Village to create additional M&A opportunities in North Carolina, as Village has had a strong brand in that state and has acquisition experience of their own over the past few years. Since the transaction did not close until last week, there is no impact from Village included in our third quarter financial performance. Our updated full-year 2026 outlook does include the expected contribution from the closing date of November 6th through December 31st. To briefly summarize the transaction, it included $39.1 million of base consideration plus $6.9 million of contingent consideration.
The $39.1 million base was funded with a mix of cash, our existing credit facility, and stock. We issued 475,000 shares as a component of that, representing approximately 24% of the consideration. We also amended our credit facility to expand the line of credit from $15 million to $25 million in conjunction with the closing. The contingent consideration is based on Adjusted EBITDA targets and doctor retention, and will be paid in cash if achieved in future periods. Turning to guidance. Based on our performance through the first nine months of 2026, our current expectations for the remainder of the year, and the post-closing contribution from Village Family, we are updating our full-year 2026 outlook. Revenue of $262 million-$265 million, compared with prior outlook of $256 million-$260 million.
Adjusted EBITDA $21.2 million-$22.2 million, compared with prior outlook of $21 million-$23 million, and Adjusted EBITDA margins of 8.1%-8.4%. The updated outlook incorporates our current assumptions for patient demand, clinical capacity, and operating costs. It also includes Village Family projections from November 9th through the end of the year, increased investment in hygiene hiring, which we expect to yield additional volume in 2027, and also the third quarter cyber event. We expect to provide our full-year 2027 outlook in connection with our fourth quarter and full-year 2026 results, tentatively planned for early March 2027. In summary, we were pleased with the third quarter revenue and same-practice growth, and we remain confident in our full-year outlook. We have added clinical capacity, completed an important acquisition, and maintained financial flexibility.
FULL TRANSCRIPT
Continue the full translated transcript in StockNow.
Log in to unlock every statement, the English original, and speaker-by-speaker history.
Log in for the full transcriptCall participants
5 people spoke on this call — only 2 are shown here.
PARTICIPANT LIST
View participant details in StockNow.
Log in to see executives and analysts, their roles, and complete speaking history.
Log in to view all participantsKeep exploring
